Skip to main content

Table 4 Baseline characteristics stratified by treatment (Cohort B )

From: Smoking status and survival: impact on mortality of continuing to smoke one year after the angiographic diagnosis of coronary artery disease, a prospective cohort study

Clinical characteristics

Medical

Revascularization

p-value

No.

2123

2123

 

BMI, Mean (SD)

28.8 (5.6)

28.8 (5.2)

1

Age, Mean (SD)

66.5 (10.8)

66 (10.3)

0.2

Female (%)

24.6

25.4

0.6

Current smoker (%)

18.6

18.5

1

Renal disease (%)

3.9

3.9

1

Liver/ GI disease (%)

8.2

8.9

0.4

Diabetes Mellitus (%)

26.6

25.6

0.4

Hyperlipidemia (%)

78.8

78.9

1

Malignancies (%)

5.1

5.3

0.7

Pulmonary disease (%)

16.9

17.2

0.8

Heart Failure (%)

13.8

12.0

0.07

Hypertension (%)

72.4

72.5

1

CVD (%)

7.6

8.0

0.7

PVD (%)

8.6

8.7

0.9

ST-Elevated MI (%)

11.4

10.7

0.5

Non ST-Elevated MI (%)

18.8

18.6

0.8

Prior MI (%)

28.0

27.5

0.7

Prior PCI (%)

5.9

6.2

0.6

Prior CABG (%)

7.2

5.9

0.1

Prior lytic (%)

2.7

2.7

1

ACS (%)

42.1

41.9

0.9

Indication for angiography (%)

  

0.9

  Acute/recent MI

26.1

25.5

 

  Unstable angina

17.1

17.6

 

  Stable angina

49.3

49.0

 

  Other*

7.5

7.9

 

Ejection fraction (%)

  

0.1

  >50%

63.0

66.0

 

  35-50%

16.0

14.6

 

  20-34%

6.2

5.1

 

  <20%

1.8

1.3

 

  Not done

7.0

6.2

 

Coronary Anatomy (%)

  

0.7

  Normal

0.2

0

 

  <50% disease

0.3

0.3

 

  Low risk (1–2 VD)

66.1

67.2

 

  High Risk (2–3 VD)

28.3

27.5

 

  Left Main disease

5.1

4.9

 
  1. SD: Standard deviation, BMI: body mass index, CVD: Cerebrovascular disease, PVD: Peripheral vascular disease, MI: myocardial infarction, PCI: Percutaneous Coronary Intervention, CABG: Coronary Artery Bypass Grafting, ACS: Acute coronary syndrome, VD: vessel disease. *Other include silence ischemia, evaluation of serious arrhythmia, preoperative assessment, research protocol angiography.